restrictive homozygous IGHG * bfn/ * bfn diplotype, 34% at age 1, increasing to 60% at age 10, rating the highest numbers of positive IgE tests, expressing increased levels of IgE and innate IgG2 * n. Conclusions: The IGHG * bfn haplotype (B * bfn cells) and increased innate IgG2 * n levels are predictive factors for IgE sensitization in childhood. IGHG genes can be assessed for prognostic and preventive purposes in clinical care.
Several candidate genes have been found associated with the inflammatory response of IgE-mediated allergy [1] [2] [3] . Asthma and allergy are linked to the IGHG (Fcγ) (genetic marker, GM) genes, replicated in several studies by serological methods [4] [5] [6] [7] . Serological IGHG gene mapping, based on alternative mendelian GM allotypes of γ3, γ1 and γ2 on chromosome 14q32.3 (5´-μ, δ, γ3, γ1, ψε, α1, γ2, γ4, ε, α2-3´), have identified new innate IgG subclasses and new B cells. There is no genetic marker for IgE but IgG genes are informative. IGHG (Fc) (GM) genes are associated with allergen IgE sensitization [8] [9] [10] [11] [12] [13] [14] . Ge-nome-wide association studies have not included GM genes in their genotyping platform [15] [16] [17] and have missed IGHG as candidate gene.
The alternative GM allotypes are for γ3-chains * b/5 and/or * g/21, for γ1-chains * f/3 and/or * a/1, and for γ2-chains * n/23 and/or * -n/-23. There are 10 homozygous and heterozygous individual IGHG diplotypes, made up by combinations of 4 fixed IGHG haplotypes: IGHG * bfn , IGHG * bf-n , IGHG * gan and IGHG * ga-n, markers of Bcell variants: B * bfn (B1), B * bf-n (B2), B * gan (B3) and B * ga-n (B4) [14] . The IGHG gene complex, dissected in alleles (allotypes), genotypes, haplotypes and diplotypes and innate IgG subclass levels are registered [18, 19] . A gene map and reference serum levels of healthy Caucasians are given (see online suppl. addendum; for all online suppl. material, see www.karger.com/doi/10.1159/000371351). The innate alternative IgG subclass variants differ by structure and function, by amino acids [5] , by electrophoretic and chromatographic rates [20] , by developmental rate during childhood [19] , by half-life times [21] , by different results on vaccination [22, 23] and treatment with monoclonal humanized antibodies [24] . Allergens, bacteria [22, 23] and virus [25] [26] [27] affect IGHG genes of individuals differently and relate to the diseases as allergy [7] [8] [9] [10] [11] [12] , primary immunodeficiency [28] , autoimmunity [29, 30] and malignancy [31, 32] .
Restrictive IGHG genes are found in patients with clinical allergy, increased IgE levels, increased IgG4 levels, with a family history of allergy and in technicians exposed to laboratory animals developing laboratory animal allergy [7] [8] [9] [10] . The IGHG genes are linked to different phenotypes of childhood asthma: the IGHG * bfn to IgE-mediated and the IGHG * bf-n and IGHG * ga-n to infectionprone asthma, combined with low levels of IgG [7] .
The aim of the study was to investigate, if IGHG genes can predict the development of atopy in children. The rate of food and aeroallergen IgE sensitization was investigated in IGHG diplotypes, IGHG haplotypic B cells, IGHG2 genes and IgG subclass levels of children aged 1 and 10 years, from the Multicenter Allergy Study (MAS). The serum levels of innate IgG subclass molecules were assessed [7] in 10-year-old IgE-sensitized children.
Materials and Methods

Study Population
The study population comprised 194 Caucasian children from the German MAS birth cohort, with case and controls from the same group of patients. Details of recruitment and the study subjects have been reported previously [33] . For the present analyses, we used data on allergic sensitization from the 1-year and 10-year follow-up assessments. The research protocol was approved by the ethical review board of the coordinating center (Charité University Medical Center, Berlin, Germany).
Assessment of Allergic Sensitization
Specific sensitization to 4 food allergens (hen's egg, cow's milk, soy and wheat) and 5 common indoor and outdoor aeroallergens (house dust mite, cat, dog, birch pollen and timothy grass pollen) was assessed as specific IgE antibodies in blood of 1-and 10-yearold children, respectively, by utilizing ImmunoCAP (Phadia AB, Uppsala, Sweden). Children were regarded as sensitized if the specific IgE to at least 1 allergen was ≥ 0.35 kU/l. The analyses were performed by Phadia Laboratories in Berlin.
IGHG Genotyping and Quantification of Innate IgG Subclass Levels
The IGHG genes were assessed by serological IGHG (Fcγ) (GM) gene mapping based on alternative GM allotypes for quality and quantity. The GM allotypes are genetic markers on the constant heavy G chains, the Fc part of the molecule. The alternative allotypes of γ3, γ1 and γ2 are distinctive unique entities with different structures and functions. IGHG genes and innate IgG subclasses were investigated for quality and quantity with new serological methods: competitive ELISA, double immunodiffusion, Mancini technique [6, 13] .
Sera from a hundred and ninety-four 10-year-old and a hundred and fifty-nine 1-year-old children from the MAS were genotyped defining individual IGHG diplotypes, IGHG haplotypes (Bcell variants), IGHG subclass genotypes and alternative IGHG allotypes (alleles). The very rare diplotypes (totally <1-2% of Caucasians) were left out. By the tests the quantitative expressions of IGHG genes are available. Total IgG subclass levels were measured with the Mancini technique. Innate IgG subclass levels were assessed in IgE-sensitized patients with homozygous IGHG * bfn/ * bfn diplotypes and heterozygous IGHG * bfn/ * bf-n and compared to not sensitized age-and IGHG -matched children from the MAS.
Statistical Analysis
The data were analyzed by the SPSS statistical package, SPSS 11.5, χ 2 test and 2 by 2 tables employing the 'Wald' approximation of the variance of the odds ratios (OR), similar to simple logistic regression with an estimate of the OR for the final model variables and associated 95% confidence intervals (CI). A p value <0.05 was considered statistically significant. The serum levels of allelic innate IgG subclasses of IgE-sensitized patients with the IGHG * bfn/ * bfn and IGHG * bfn/ * bf-n diplotypes were compared to nonsensitized age-and IGHG-matched controls with the z-test.
Results
The 'Atopic March' in IGHG Diplotypes, IGHG Haplotypes and IGHG2 Genotypes
The IgE sensitization rate for children at 1 and 10 years of age, the 'atopic march', was recorded. The atopic march was most prominent within the homozygous IGHG * bfn/ * bfn (B1/B1) diplotype, with an increase 27 from 12/35 = 34% to 27/45 = 60% sensitized (online suppl. table 1). The various specific allergen sensitizations within homozygous IGHG * bfn/ * bfn were rated from 38 to 60% in 1-year-old and from 25 to 39% in 10-year-old children, respectively. The remaining 2 homozygous diplotypes showed lower rates of sensitization, IGHG * bfn/ * bf-n (B2/B2) from 0/7 = 0% to 6/9 = 67% and IGHG * gan/ * ga-n (B4/B4) from 1/19 = 5% to 9/21 = 43%, respectively. The specific allergen sensitization within IGHG * bf-n/ * bf-n was 0% in 1-year-olds and 0-7% in 10-year-olds and within IGHG * ga-n/ * ga-n 0-4% in 1-year-olds and 8-15% in 10-year-olds, respectively. Thus, the IGHG2 * -n/ * -n was not involved in the food sensitization but to some degree in aeroallergen sensitization. IgE sensitization was increased within the homozygous IGHG2 * n/ * n ( IGHG * bfn/ * bfn ) genotype compared to the opposite IGHG2 * -n/ * -n , containing IGHG * bf-n and IGHG * ga-n haplotypes (OR 2.9, 95% CI 1.1-7.2; p = 0.022). The atopic march for cat allergy was most prominent for IGHG * bfn/ * bfn : 2 in 1-year-olds and rising to 15 in 10-year-olds, compared to the other homozygous diplotypes for IGHG * bf-n/ * bf-n from 0 to 1 and for IGHG * ga-n/ * ga-n from 0 to 3 in 1-and 10-year-olds, respectively (online suppl. table 1a, b). . tables 2a,  3a) . The opposite IGHG * ga-n haplotype and B * ga-n (B4) cells with the IGHG2 * -n allele were instead significantly decreased in all sensitized children (n = 14, OR 0.5, 95% CI 0.3-0.9; p = 0.030).
IgE Sensitization in IGHG Haplotypes
Of 99 sensitized 10-year-old children (198 IGHG haplotypes), the IGHG * bfn haplotype, B * bfn (B1) cells and the IGHG2 * n allele frequencies were significantly increased in all sensitized (n = 101, OR 1.4, 95% CI 1.02-1.9; p = 0.034; online suppl. tables 2b, 3b) and in specific birchsensitized (n = 61, OR 2.0, 95% CI 1.3-3.0; p < 0.001), in grass-sensitized (n = 77, OR 1.4, 95% CI 1.0-2.0; p = 0.050), in cat-sensitized (n = 45, OR 1.9, 95% CI 1.2-3.1; p = 0.006) and in dog-sensitized (n = 46, OR 1.4, 95% CI 1.02-1.9; p = 0.034) compared to 95 nonsensitized children (online suppl. tables 2b, 3b). In this age group, the frequency of the opposite IGHG * ga-n haplotype and B * ga-n (B4) cells did not differ when compared to nonsensitized children. The IGHG gene frequencies of 124 of the 1-year-old and of 95 non-IgE-sensitized 10-year-old children did not deviate from those of a healthy Caucasian population (Hardy-Weinberg equilibrium p > 0.5; online suppl. material, gene map).
Positive IgE Tests Associated with IGHG2 * n Alleles
Next, we investigated the quality of IgE sensitization by the numbers of positive IgE tests per person, at different ages. We found that carriers of the homozygous IGHG * bfn/ * bfn including homozygous IGHG2 * n/ * n had higher numbers of positive IgE tests than carriers of the alternative IGHG2 * -n/ * -n 2.3 versus 1.0 positive tests per patient in 1-year-olds and 4.5 versus 3.2 positive tests per patient in 10-year-olds.
Increased Innate IgG2 * n Subclass Levels in IgE-Sensitized Individuals with the Homozygous IGHG * bfn/ * bfn and Heterozygous IGHG * bfn/ * bf-n Diplotypes Twenty-seven IgE-sensitized 10-year-old children compared to 18 nonsensitized ones, with homozygous IGHG * bfn/ * bfn, demonstrated significantly increased amounts of the allelic innate IgG2 * n subclass (1.21 ± 0.43 g/l) and IgE (567.29 ± 630.31 kU/l) levels compared to nonsensitized IgG2 * n (0.92 ± 0.44 g/l) and IgE (25.20 ± 20.48 kU/l), respectively (online suppl. table 4). Also 26 IgE-sensitized compared to 26 nonsensitized heterozygous IGHG * bfn/ * bf-n subjects with only 1 IGHG * bfn haplotype and 1 IGHG2 * n allele demonstrated significantly increased IgG2 * n (0.70 ± 0.24 g/l) and IgE (332.97 ± 314.37 kU/l) levels compared to IgG2 * n (0.55 ± 0.24 g/l) and IgE (45.80 ± 52.95 kU/l), respectively. The level of IgG2 * -n was left out.
Discussion
IGHG (γ) genes are in linkage disequilibrium with the IGHE (ε) gene on chromosome 14q32.3 (5´-μ, δ, γ3, γ1, ψε α1, γ2, γ4, ε, α2-3´). In the absence of genetic markers for IGHE , the IGHG genes are informative. The alternative GM allotypes of γ3-, γ1-and γ2-chains, respectively, were identified with a new sensitive competitive ELISA, defining the interindividual variability of innate IgG subclasses and innate B cells [13, 14] . The alternative GM allotypes are markers of the Fcγ part of the IgG molecules which differ by structures and functions [5] . Specific IGHG genes are involved in IgE sensitization of allergy patients [7] [8] [9] [10] [11] [12] . Genome-wide association studies and HapMap do not include GM allotypes in their genetic platforms. This has underestimated IGHG as candidate gene in immunobiology and allergy [15] [16] [17] .
We demonstrate a significant association of IGHG * bfn haplotypes with innate IgG3 * b, IgG1 * f and IgG2 * n expressed from the innate B * bfn (B1) cells, in 1-year-old children IgE sensitized with food allergens and in10-year-old children IgE sensitized with aeroallergens (online suppl. tables 2, 3). IgE sensitization was most prominent in the homozygous IGHG * bfn/ * bfn with IGHG * bfn inherited from both parents. The number of IgE sensitized in homozygous IGHG * bfn/ * bfn rose from 12/35 (34%) in 1-yearolds, to 27/45 (60%) in 10-year-olds, demonstrating the 'atopic march'. Homozygous IGHG2 * n/ * n contained the dominating numbers of positive IgE tests/individual, compared to the opposite homozygous IGHG2 * -n/ * -n . The innate IgG2 * n levels were significantly increased in IgE-sensitized carriers, in homozygous IGHG * bfn/ * bfn and heterozygous IGHG * bfn/ * bf-n , compared to age-and IGHG -matched nonsensitized children (online suppl. table 4). Increased innate IgG2 * n levels have been recorded in IgE-mediated childhood asthma [7] . The activated IGHG2 * n allele is probably taking part in the IgE sensitization process. The γ2-genes are located 18 kb from the γ4 and another 23 kb from the ε-genes on chromosome 14q32.3, which part is activated by IL-4 and IL-13 cytokines from Th2 lymphocytes [34, 35] . Genome-wide association studies have been rather insufficient to capture causal allergy gene variants. However, recently a finemapping study of IgE-associated loci confirmed and identified single-nucleotide polymorphisms of chromosome 5q31 regulating the Th2 cytokines IL-4 and IL-13 [36] . The finding of significantly increased IgG2 * n levels in IgE-sensitized children is highlighted and must be compared with the slow rate of increasing IgG2 * n levels during childhood in healthy children [7, 20] . The stimulation by allergens of both the IGHG2 * n allele and IGHE genes, avoiding activation of IGHG3 * b and IGHG1 * f alleles upstream, known to be activated by infections in healthy controls, might be in agreement with the hygiene hypothesis. The present paradigm dictates that atopy is accomplished mainly by the effect of IGHE , but the whole IGH haplotype, where both IGHG and IGHE genes are involved, gives the particular innate IgG molecules IgG3 * b, IgG1 * f and IgG2 * n a role in allergy, probably in the early sensitization process as the IGHG genes are activated before the downstream located IGHE . The IGHG * bfn haplotype including the IGHG2 * n allele and increased IgG2 * n levels are most prominent risk factors for IgE sensitization.
In 1-year-old children, food allergens had affected individuals with the IGHG * bfn haplotype (B1 cells) more often than those with the other haplotypes. A negative association of the opposite IGHG2 * -n allele with allergen sensitization was observed. The homozygous IGHG2 * -n/ * -n genotype demonstrated a weaker sensitization rate (online suppl. tables 1-3). In 10-year-olds, aeroallergens affected mainly the same IGHG * bfn, but the IgE sensitization was found to some degree also in IGHG * bf-n and IGHG * ga-n haplotypes, with the IGHG2 * -n allele (online suppl. tables 1b, 2b). But when equal numbers of the 6 most common IGHG diplotypes of a childhood asthma cohort were investigated, the homozygous IGHG * bfn/ * bfn was linked to atopy and the different homozygous IGHG * bf-n/ * bf-n and IGHG * ga-n/ * ga-n were linked to low levels of IgE, low IgE sensitization and low levels of innate IgG subclasses as in IgG subclass deficiencies [7] .
B cells are the only cells producing antibodies, and B cells can indirectly be defined by IGHG genes [14] . IGHG genes of B cells are found in all human somatic cells, also stem cells [34] . All genes constituting the IGHG haplotype have an impact on the expressed levels of innate IgG subclasses, as it has been demonstrated in both immunodeficient and healthy individuals [19, 20, 28] . The function of the immunoglobulin G molecule is related to the constant part of the heavy G chains, the Fcγ part of the molecule, in parallel to the function of the variable adaptive antibody binding site. The IGHG (Fcγ) (GM) allotypes with epitope differences in the Fc part of the molecule have influence on the outcome of both bacterial and viral infections. Individuals with the IGHG * bfn haplotype are high producers of antibodies against encapsulated bacteria and in vaccination with bacterial polysaccharides [22, 23] . The influence of viral particles acting as FcγRs with preference of binding to different IGHG (Fcγ) allotypes [25] [26] [27] is important and can be applied also to allergic disease, possibly related to exacerbations. Severe infections in infants with respiratory syncytial virus are associated with the IGHG * bf-n/ * bf-n diplotype and the IGHG2 * -n alleles [35] .
IGHG genes can predict different phenotypes in childhood asthma and must be investigated in other forms of allergy. Active and passive immunotherapy, such as allergy vaccination and treatment with humanized recombinant monoclonal antibodies, affects individuals with different IGHG diplotypes with different results. IGHG genes must be investigated in relation to other genes and biomarkers with a known association to IgE-mediated allergy.
